SEARCH

SEARCH BY CITATION

References

  • Adhikary, P.K., Hara, S., Dwivedi, C., Davis, J.W., Weaver, C. & Pavuluri, S.R. (1986) Vaso-occlusive crisis episodes in sickle cell disease. Journal of Medicine, 17, 227240.
  • Aessopos, A., Farmakis, D., Karagiorga, M., Voskaridou, E., Loutradi, A., Hatziliami, A., Joussef, J., Rombos, J. & Loukopoulos, D. (2001) Cardiac involvement in thalassemia intermedia: a multicenter study. Blood, 97, 34113416.
  • Aslan, M., Ryan, T.M., Adler, B., Townes, T.M., Parks, D.A., Thompson, J.A., Tousson, A., Gladwin, M.T., Patel, R.P., Tarpey, M.M., Batinic-Haberle, I., White, C.R. & Freeman, B.A. (2001) Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Procedings of the National Academy of Sciences of the United States of America, 98, 1521515220.
  • Ballas, S.K. & Marcolina, M.J. (2006) Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion, 46, 105110.
  • Blum, A., Yeganeh, S., Peleg, A., Vigder, F., Kryuger, K., Khatib, A., Khazim, K. & Dauerman, H. (2005) Endothelial function in patients with sickle cell anemia during and after sickle cell crises. Journal of Thrombosis and Thrombolysis, 19, 8386.
  • Castro, O., Hoque, M. & Brown, B.D. (2003) Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood, 101, 12571261.
  • Charache, S. (1994) Sickle cells and sudden death. Journal of Laboratory and Clinical Medicine, 124, 473474.
  • Chou, R. & DeLoughery, T.G. (2001) Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency. American Journal of Hematology, 67, 197199.
  • Du, Z.D., Roguin, N., Milgram, E., Saab, K. & Koren, A. (1997) Pulmonary hypertension in patients with thalassemia major. American Heart Journal, 134, 532537.
  • Eberhardt, R.T., McMahon, L., Duffy, S.J., Steinberg, M.H., Perrine, S.P., Loscalzo, J., Coffman, J.D. & Vita, J.A. (2003) Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. American Journal of Hematology, 74, 104111.
  • Ergul, S., Brunson, C.Y., Hutchinson, J., Tawfik, A., Kutlar, A., Webb, R.C. & Ergul, A. (2004) Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction. American Journal of Hematology, 76, 245251.
  • Gladwin, M.T., Lancaster, Jr, J.R., Freeman, B.A. & Schechter, A.N. (2003a) Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nature Medicine, 9, 496500.
  • Gladwin, M.T., Schechter, A.N., Ognibene, F.P., Coles, W.A., Reiter, C.D., Schenke, W.H., Csako, G., Waclawiw, M.A., Panza, J.A. & Cannon, III, R.O., (2003b) Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation, 107, 271278.
  • Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. & Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 886895.
  • Groves, B.M. & Badesch, D. (2004) Cardiac catheterization of patients with pulmonary hypertension. In: Pulmonary Circulation: Disease and their Treatment (ed. byA.J.Peacock & L.J.Rubin), pp. 121131. Arnold, London.
  • Hammerman, S.I., Kourembanas, S., Conca, T.J., Tucci, M., Brauer, M. & Farber, H.W. (1997) Endothelin-1 production during the acute chest syndrome in sickle cell disease. American Journal of Respiratory and Critical Care Medicine, 156, 280285.
  • Hassoun, P.M. & Krishnan, J.A. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 25212522; author reply 2521–2522.
  • Heller, P.G., Grinberg, A.R., Lencioni, M., Molina, M.M. & Roncoroni, A.J. (1992) Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria. Chest, 102, 642643.
  • Jardine, D.L. & Laing, A.D. (2004) Delayed pulmonary hypertension following splenectomy for congenital spherocytosis. Internal Medicine Journal, 34, 214216.
  • Jubelirer, S.J. (1991) Primary pulmonary hypertension. Its association with microangiopathic hemolytic anemia and thrombocytopenia. Archives of Internal Medicine, 151, 12211223.
  • Kato, G.J., McGowan, V., Machado, R.F., Little, J.A., Taylor, VI, J.G., Morris, C.R., Nichols, J., Wang, X., Poljakovic, M., Morris, Jr, M. & Gladwin, M.T. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood, 107, 22792285.
  • Kaul, D.K., Liu, X.D., Chang, H.Y., Nagel, R.L. & Fabry, M.E. (2004) Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. Journal of Clinical Investigation, 114, 11361145.
  • Klings, E.S. & Farber, H.W. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 25212522. author reply 2521–2522.
  • Labrune, P., Zittoun, J., Duvaltier, I., Trioche, P., Marquet, J., Niaudet, P. & Odievre, M. (1999) Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency. European Journal of Pediatrics, 158, 734739.
  • Minneci, P.C., Deans, K.J., Zhi, H., Yuen, P.S., Star, R.A., Banks, S.M., Schechter, A.N., Natanson, C., Gladwin, M.T. & Solomon, S.B. (2005) Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. Journal of Clinical Investigation, 115, 34093417.
  • Morris, C.R., Morris, Jr, S.M., Hagar, W., Van Warmerdam, J., Claster, S., Kepka-Lenhart, D., Machado, L., Kuypers, F.A. & Vichinsky, E.P. (2003) Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? American Journal of Respiratory and Critical Care Medicine,, 168, 6369.
  • Morris, C.R., Kato, G.J., Poljakovic, M., Wang, X., Blackwelder, W.C., Sachdev, V., Hazen, S.L., Vichinsky, E.P., Morris, Jr, S.M. & Gladwin, M.T. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. Journal of the American Medical Association, 294, 8190.
  • Naumann, H.N., Diggs, L.W., Barreras, L. & Williams, B.J. (1971) Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. American Journal of Clinical Pathology, 56, 137147.
  • Neely, C.L., Wajima, T., Kraus, A.P., Diggs, L.W. & Barreras, L. (1969) Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease. American Journal of Clinical Pathology, 52, 167169.
  • Nolan, V.G., Wyszynski, D.F., Farrer, L.A. & Steinberg, M.H. (2005) Hemolysis associated priapism in sickle cell disease. Blood, 106, 32643267.
  • Parfrey, N.A., Moore, W. & Hutchins, G.M. (1985) Is pain crisis a cause of death in sickle cell disease? American Journal of Clinical Pathology, 84, 209212.
  • Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 16391644.
  • Reiter, C.D. & Gladwin, M.T. (2003) An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Current Opinion in Hematology, 10, 99107.
  • Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, R.O., Schechter, A.N. & Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 13831389.
  • Rother, R.P., Bell, L., Hillmen, P. & Gladwin, M.T. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA, 293, 16531662.
  • Rybicki, A.C. & Benjamin, L.J. (1998) Increased levels of endothelin-1 in plasma of sickle cell anemia patients. Blood, 92, 25942596.
  • Schechter, A.N. & Gladwin, M.T. (2003) Hemoglobin and the paracrine and endocrine functions of nitric oxide. New England Journal of Medicine, 348, 14831485.
  • Schnog, J.J., Jager, E.H., Van Der Dijs, F.P., Duits, A.J., Moshage, H., Muskiet, F.D. & Muskiet, F.A. (2004) Evidence for a metabolic shift of arginine metabolism in sickle cell disease. Annals of Hematology, 83, 371375.
  • Sutton, L.L., Castro, O., Cross, D.J., Spencer, J.E. & Lewis, J.F. (1994) Pulmonary hypertension in sickle cell disease. American Journal of Cardiology, 74, 626628.
  • Verresen, D., De Backer, W., Van Meerbeeck, J., Neetens, I., Van Marck, E. & Vermeire, P. (1991) Spherocytosis and pulmonary hypertension coincidental occurrence or causal relationship? European Respiratory Journal, 4, 629631.
  • Wang, X., Tanus-Santos, J.E., Reiter, C.D., Dejam, A., Shiva, S., Smith, R.D., Hogg, N. & Gladwin, M.T. (2004) Biological activity of nitric oxide in the plasmatic compartment. Proceedings of the National Academy of Sciences of the United States of America, 101, 1147711482.
  • Weiss, B.M. & Hess, O.M. (2000) Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. European Heart Journal, 21, 104115.